Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
April 2024
The medical devices information portal connecting healthcare professionals to global vendors
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy
Oxytocin improves brain function in children with autism
, /in E-News /by 3wmediaPreliminary results from an ongoing, large-scale study by Yale School of Medicine researchers shows that oxytocin
Musical pacifier invention to help premature babies one lullaby at a time
, /in E-News /by 3wmediaPAL brings the healing power of music to premature infants.
Many premature babies enter the world with a mountain of challenges in front of them. Even after they overcome any life-threatening issues, they face ongoing, and typically unpleasant, medical procedures, long hospital stays and increased chances of chronic health issues throughout their lives.
To help address one of their biggest problems
A non-invasive intracellular ‘thermometer’ with fluorescent proteins has been created
, /in E-News /by 3wmediaA team from the Institute of Photonic Sciences (ICFO) has developed a technique to measure internal cell temperatures without altering their metabolism. This finding could be useful when distinguishing healthy cells from cancerous ones, as well as learning more about cellular processes.
Temperature controls many of the cell’s life processes, such as splitting and metabolism. A European research team led by the Institute of Photonic Sciences (ICFO), which has the Severo Ochoa mark of excellence, has published a non-invasive method that offers quicker, more precise data from measuring intracellular heat from green fluorescent proteins (GFP).
‘A unique characteristic of our method is that it does not alter any cellular process’ Romain Quidant, ICFO researcher and study co-ordinator, explains to SINC. Unlike other techniques, this method does not stress or alter the behaviour of the cell as it does not need to be inserted into any molecules or any other synthetic nano-object that is sensitive to the internal temperature.
One of the most promising outcomes is a better understanding of cellular processes, such as those involved in metastasis. Furthermore, the possibility of obtaining information about intracellular temperature could be used to ‘differentiate normal cells from cancerous ones in a quick, non-invasive manner’ Sebastian Thompson Parga, ICFO researcher and co-author of the project.
From intracellular temperature, we can deduce how the energy used by the body in the uncontrolled spreading of cancer cells flows.
In this interdisciplinary study, biology uses physical measurements of energy transmission to study processes such as gene expression, metabolism and cell splitting.
The technique used is known by the name of ‘fluorescence polarisation anisotropy’ (FPA) as it allows the difference in polarisation between light that fluorescent molecules receive, and that which they emit later, to be measured. In the words of Quidant, ‘this difference in polarisation (anisotropy) is directly connected to the rotating of the GFP molecules and therefore with temperature’.
The authors of the study ensure that biologists will be able to implement this technique in experimental set-ups and obtain the cell temperature as another observable detail. In 2008, when Osamu Shimomura, Martin Chalfie and Roger Y. Tsien won the Nobel Chemistry Prize for discovering and developing GFP, they resolved many complications in biomedical research. EurekAlert
Breast MRI helps predict chemotherapy’s effectiveness
, /in E-News /by 3wmediaMagnetic resonance imaging (MRI) provides an indication of a breast tumour
Stroke clot-buster trial shows benefit
, /in E-News /by 3wmediaPatients given a clot-busting drug within six hours of a stroke are more likely to make a better recovery than those who do not receive the treatment.
The multi-centre, randomised study of more than 3000 patients is the world
70 percent of women use contraceptives during their first sexual encounter
, /in E-News /by 3wmediaContraceptive use in Spain during the first sexual encounter is similar to other European countries. However, there are some geographical differences between Spanish regions: women in Murcia use contraceptives less (55.8%) whereas women in the Basque Country use them more (76.7%).
Spanish researchers have analysed the prevalence of contraceptive use during the first sexual encounter over the last month in 5,141 sexually active women between the ages of 15 and 49 years through Spain’s 17 autonomous communities.
‘Bearing in mind the individual factors amongst women that determine contraceptive use, living in one autonomous community or another also has an influence,’ as explained to SINC by Dolores Ruiz Mu
Phone contact with nurses linked with better outcomes for women with gestational diabetes
, /in E-News /by 3wmediaAmong women with gestational diabetes mellitus, referral to a telephone-based nurse management program was associated with lower risk of high baby birth weight and increased postpartum glucose testing, according to Kaiser Permanente researchers.
Investigators for the Kaiser Permanente Northern California Division of Research examined the associations between referral to telephone-based nurse consultation and outcomes in 12 Kaiser Permanente medical centres with variation in the percent of patients referred to telephonic nurse management.
‘Compared with women from Kaiser Permanente medical centres where the annual proportions of referral to nurse management at the Kaiser Permanente Regional Perinatal Service Center was less than 30 percent, women who delivered in medical centres with an annual referral proportion of greater than 70 percent were less likely to have a high birth weight infant without increasing the risk or having a low birth weight infant,’ said Assiamira Ferrara, MD, PhD, a research scientist with the Kaiser Permanente Northern California Division of Research and the lead author of the study. ‘In addition, they were more likely to have postpartum glucose testing, which leads to earlier identification and management of postpartum glucose intolerance or diabetes.’
Investigators used data from the Kaiser Permanente Northern California GDM registry to identify women who had pregnancy complicated by GDM from 1997 through 2006. They restricted their cohort to women with GDM according to the National Diabetes Data Group criteria. During the study period, 96 percent of all pregnant women without pre-existing diabetes who delivered an infant were screened for GDM. Researchers excluded women who delivered multiple births due to their increased risk of perinatal complications. Overall, researchers identified 11,435 women with GDM at the 12 medical centres, of whom 44.5 percent were referred to the perinatal service centre.
‘The Kaiser Permanente Regional Perinatal Service Center is a nurse-based management program for women with GDM that offers supplemental care via telephone counselling to women with high-risk pregnancies, including those complicated by GDM,’ explained co-author Monique Hedderson, PhD, a research scientist with the Kaiser Permanente Northern California Division of Research.
The program includes a call center with 32 registered nurses and two registered dieticians who offer phone counselling seven days a week and address glucose monitoring and control, diet and physical activity. Nurses are available 24 hours a day, seven days a week, while dieticians are available to patients during the week from 8 a.m. to 5 p.m. In addition to care provided by obstetricians, women referred to the centre receive one to two counselling calls per week to help them manage their blood glucose levels during pregnancy. The centre also sends a laboratory slip for postpartum glucose testing and a reminder telephone call if the screening test was not performed. EurekAlert
Cyber exercise partners help you go the distance
, /in E-News /by 3wmediaA new study testing the benefits of a virtual exercise partner shows the presence of a moderately more capable cycling partner can significantly boost the motivation
Device may inject a variety of drugs without using needles
, /in E-News /by 3wmediaGetting a shot at the doctor
New technology used by Mayo Clinic treats evaporative dry eye symptoms
, /in E-News /by 3wmediaMayo Clinic in Arizona is the first medical centre in Arizona and the Southwest to provide a new technology that treats dry eye by targeting blocked eyelid glands. Blocked glands can inhibit production of oil that is necessary for healthy tears needed to lubricate the eyes.
People with chronic dry eye, from this evaporative sub-type , often experience pain and irritation caused by an inadequate protective layer of oils in their tears, which creates a cycle where they resort to excessive use of eye drops that can exacerbate the condition, according to Joanne Shen, M.D., Ophthalmology, Mayo Clinic in Arizona. ‘Patients are frustrated in their attempts to find relief, frequently trying warm compresses, ointment, eye drops or even vitamins,’ says Dr. Shen.
The new treatment, called the LipiFlow thermal pulsation system, represents a significant shift from the traditional management of dry eye, in that the system is able to diagnose and address the root cause of the condition